Back to today’s briefing

Story perspectives

Switzerland Approves Infant Malaria Drug Amid Uganda Crisis

8/20/2025

41 5

Summary

Story summary

Swiss regulators approved Coartem Baby, a malaria treatment for infants, targeting high mortality rates in Uganda.
The drug is designed for babies weighing 2-5 kg and has a sweet taste to improve accessibility.
In 2023, Uganda reported 12.6 million malaria cases and nearly 16,000 deaths, heavily affecting children and pregnant women.

1 of 1

Story summary

Swiss regulators approved Coartem Baby, a malaria treatment for infants, targeting high mortality rates in Uganda.
The drug is designed for babies weighing 2-5 kg and has a sweet taste to improve accessibility.
In 2023, Uganda reported 12.6 million malaria cases and nearly 16,000 deaths, heavily affecting children and pregnant women.